Transcription of Financial statements - GSK
{{id}} {{{paragraph}}}
Investor informationFinancial statementsStrategic reportGovernance and remunerationGSK Annual Report 2020 139 Financial statementsIn this sectionDirectors statement of responsibilities 140 Independent Auditor s report 142 Financial statements 154 Notes to the Financial statements 158 Financial statements of GlaxoSmithKline plc prepared under UK GAAP 238 Investor informationFinancial statementsStrategic reportGovernance and remunerationGSK Annual Report 2020 139140 GSK Annual Report 2020 The Directors are responsible for preparing the Annual Report, the Remuneration report and the Group and parent company Financial statements in accordance with applicable law and company law requires the Directors to prepare Financial statements for each Financial year. The Directors are required to prepare the Group consolidated Financial statements in accordance with International Financial Reporting Standards (IFRS), as adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union.
the Group, its financial position, cash flows, net debt position and borrowing facilities. Further information, including Treasury risk management policies, exposures to market and credit risk and hedging activities, is given in Note 43 to the financial statements, ‘Financial instruments and related disclosures’.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}